Gilead’s HIV drug business grew while its Covid drug sales tanked in the first quarter of 2025, as the company recorded the ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) in Q1 CY2025, with sales flat year on year at $6.67 billion. The ...

Looking ahead, Gilead Sciences cut its full-year earnings outlook to $5.65 to $6.05 a share from a prior range of $5.95 to $6.35 a share. Analysts had been expecting full-year earnings of $6.22. The ...

(GILD) on Thursday reported first-quarter earnings of $1.32 billion. The Foster City, California-based company said it had net income of $1.04 per share. Earnings, adjusted for costs related to ...

Gilead Sciences on Thursday reported slightly higher-than-expected quarterly earnings on flat revenue, as higher sales of ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

The Mount Gilead softball team jumped out to a first-inning lead over visiting East Knox on Wednesday, but couldn’t hold onto ...

(Nasdaq: GILD) announced today its first quarter 2025 results of operations. "Gilead had a strong start to the year driven by ...

President Donald Trump's energy security council plans to host a summit in Alaska in early June, when it hopes Japanese and ...

Margaret Atwood's dystopian book The Handmaid's Tale was published in 1985 and the main storyline revolves around Offred (June).

The Scots got doubles by Zach Church and Gavin Wiggand in the win, while Jayden Collins finished with a pair of singles. Church also went six innings to earn the win. He and Collins combined to strike ...

The cast of The Handmaid's Tale visits WIRED to answer the 50 most searched for questions about the show as it enters its ...